Barclays
SKIN icon

Barclays’s SkinHealth Systems SKIN Stock Holding History

Barclays’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9 Sell
1
-345
-100% -$4.95K ﹤0.01% 5196
2026
Q2 		$4.79K Sell
346
-722
-68% -$11K ﹤0.01% 4781
2026
Q1 		$19K Sell
1,068
-7,846
-88% -$193K ﹤0.01% 4586
2025
Q4 		$248K Buy
8,914
+810
+10% +$23.4K ﹤0.01% 4208
2025
Q3 		$323K Sell
8,104
-1,922
-19% -$78K ﹤0.01% 4052
2025
Q2 		$383K Buy
10,026
+5,987
+148% +$169K ﹤0.01% 3909
2025
Q1 		$108K Sell
4,039
-1,857
-31% -$56.6K ﹤0.01% 4375
2024
Q4 		$187K Buy
5,896
+591
+11% +$18.6K ﹤0.01% 4346
2024
Q3 		$153K Buy
5,305
+3,671
+225% +$120K ﹤0.01% 4430
2024
Q2 		$62.7K Sell
1,634
-4,673
-74% -$263K ﹤0.01% 4118
2024
Q1 		$560K Sell
6,307
-668
-10% -$43.4K ﹤0.01% 3520
2023
Q4 		$434K Buy
6,975
+2,261
+48% +$170K ﹤0.01% 3973
2023
Q3 		$568K Sell
4,714
-2,548
-35% -$358K ﹤0.01% 2714
2023
Q2 		$1.22M Sell
7,262
-2,725
-27% -$566K ﹤0.01% 2182
2023
Q1 		$2.52M Buy
9,987
+2,504
+33% +$579K ﹤0.01% 2022
2022
Q4 		$1.36M Sell
7,483
-10,308
-58% -$2.23M ﹤0.01% 2554
2022
Q3 		$4.2M Buy
17,791
+8,016
+82% +$2.03M ﹤0.01% 1274
2022
Q2 		$2.51M Sell
9,775
-30,346
-76% -$8.13M ﹤0.01% 1692
2022
Q1 		$13.5M Buy
+40,121
New +$13.2M 0.01% 814

Other funds holding SKIN

Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Grimes & Company
Grimes & Company Westborough, Massachusetts $4.26B AUM 24.58% 1-Year Est. Return
CCM
Cohen Capital Management Corte Madera, California $717M AUM 30.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
MTM Investment Management
MTM Investment Management Spartanburg, South Carolina $346M AUM 17.64% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return
Cooper Financial Group
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Barclays's SKIN Position: Q3 2026 in Review

Barclays reduced its SkinHealth Systems (SKIN) stake by 100% in Q3 2026, selling an estimated $4.95K and leaving 1 share worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #5196.

Barclays first reported a position in SKIN in Q1 2022 and has held it in 19 quarters since. The position peaked at $13.5M in Q1 2022. 18 funds tracked by Wall St. Rank hold SKIN as of Q3 2026.

  • Barclays held 1 share of SkinHealth Systems worth $9 as of Q3 2026.
  • Barclays sold 345 SkinHealth Systems shares in Q3 2026, an estimated $4.95K.
  • SkinHealth Systems made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5196 holding.
  • Barclays first reported a position in SkinHealth Systems in Q1 2022 and has held it in 19 quarters since.
  • Barclays's SkinHealth Systems position peaked at $13.5M in Q1 2022.
  • 18 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.